AU8546591A - Non-aqueous liquid oral suspensions - Google Patents
Non-aqueous liquid oral suspensionsInfo
- Publication number
- AU8546591A AU8546591A AU85465/91A AU8546591A AU8546591A AU 8546591 A AU8546591 A AU 8546591A AU 85465/91 A AU85465/91 A AU 85465/91A AU 8546591 A AU8546591 A AU 8546591A AU 8546591 A AU8546591 A AU 8546591A
- Authority
- AU
- Australia
- Prior art keywords
- aqueous liquid
- liquid oral
- oral suspensions
- suspensions
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58186690A | 1990-09-13 | 1990-09-13 | |
US581866 | 1990-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8546591A true AU8546591A (en) | 1992-04-15 |
Family
ID=24326890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU85465/91A Abandoned AU8546591A (en) | 1990-09-13 | 1991-09-10 | Non-aqueous liquid oral suspensions |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0548238A1 (en) |
JP (1) | JPH06501003A (en) |
AU (1) | AU8546591A (en) |
NZ (1) | NZ239784A (en) |
PT (1) | PT98975A (en) |
WO (1) | WO1992004893A1 (en) |
ZA (1) | ZA917310B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3476447A (en) * | 1968-03-28 | 1969-11-04 | Westinghouse Electric Corp | Self-aligning hydrostatic bearing |
DE69313865T2 (en) * | 1992-10-16 | 1998-02-12 | Glaxo Group Ltd | TASTE-MASKING COMPOSITIONS OF RANITIDIN |
GB9224855D0 (en) * | 1992-11-27 | 1993-01-13 | Smithkline Beecham Plc | Pharmaceutical compositions |
US5484800A (en) * | 1994-08-30 | 1996-01-16 | American Home Products Corporation | Lipid-based liquid medicinal composition |
GB9418530D0 (en) * | 1994-09-14 | 1994-11-02 | Glaxo Group Ltd | Medicaments |
AU7468096A (en) * | 1995-10-30 | 1997-05-22 | Warner-Lambert Company | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils |
ES2153786B1 (en) * | 1999-06-10 | 2001-10-16 | S A L V A T Lab Sa | LIQUID PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF AMARGE AND SUSCEPTIBLE ACTIVE HYDROLYSIS PRINCIPLES. |
CA2468565C (en) | 2001-11-30 | 2014-06-03 | Abgenix, Inc. | Transgenic animals bearing human iglambda light chain genes |
AU2003249904A1 (en) * | 2002-07-02 | 2004-01-23 | Laboratorios S.A.L.V.A.T., S.A. | Stable oily suspension of microgranules |
US20040202696A1 (en) * | 2003-04-14 | 2004-10-14 | Cts Chemical Industries Ltd. | Administration form for veterinary use |
WO2006008640A1 (en) * | 2004-07-15 | 2006-01-26 | Pharmacia & Upjohn Company Llc | Non-aqueous suspension containing a drug having an unpleasant taste |
JP4588791B2 (en) * | 2007-02-16 | 2010-12-01 | あすか製薬株式会社 | Pharmaceutical composition comprising a particulate oily suspension |
DK2910570T3 (en) | 2008-03-18 | 2017-01-30 | Novo Nordisk As | Protease-stabilized acylated insulin analogues. |
CN102481343A (en) * | 2009-09-16 | 2012-05-30 | 诺沃—诺迪斯克有限公司 | Stable non-aqueous liquid pharmaceutical compositions comprising an insulin |
CN104364260B (en) | 2012-04-11 | 2017-02-22 | 诺和诺德股份有限公司 | insulin formulations |
GB2529605B (en) * | 2014-06-03 | 2018-03-21 | Essential Pharmaceuticals Ltd | Pharmaceutical composition |
BR102015024165A2 (en) * | 2015-09-18 | 2017-03-28 | Prati Donaduzzi & Cia Ltda | oral pharmaceutical composition comprising cannabinoid, process for its preparation and use |
HUE055231T2 (en) | 2016-12-16 | 2021-11-29 | Novo Nordisk As | Insulin containing pharmaceutical compositions |
WO2019207506A2 (en) | 2018-04-27 | 2019-10-31 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0684420B2 (en) * | 1986-12-26 | 1994-10-26 | 三菱レイヨン株式会社 | Active energy ray curable resin composition |
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
-
1991
- 1991-09-10 WO PCT/US1991/006493 patent/WO1992004893A1/en not_active Application Discontinuation
- 1991-09-10 EP EP91917176A patent/EP0548238A1/en not_active Withdrawn
- 1991-09-10 AU AU85465/91A patent/AU8546591A/en not_active Abandoned
- 1991-09-10 JP JP3516163A patent/JPH06501003A/en active Pending
- 1991-09-13 NZ NZ239784A patent/NZ239784A/en unknown
- 1991-09-13 ZA ZA917310A patent/ZA917310B/en unknown
- 1991-09-13 PT PT98975A patent/PT98975A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH06501003A (en) | 1994-01-27 |
ZA917310B (en) | 1992-10-28 |
PT98975A (en) | 1992-07-31 |
NZ239784A (en) | 1994-05-26 |
EP0548238A1 (en) | 1993-06-30 |
WO1992004893A1 (en) | 1992-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU639126B2 (en) | Oxorapamycin | |
AU614482B3 (en) | Receptacle | |
AU8536291A (en) | Liquid/liquid hydrocyclone | |
AU8546591A (en) | Non-aqueous liquid oral suspensions | |
AU626649B2 (en) | Oral medication in the form of non-aqueous suspensions | |
AU7846991A (en) | Aminobenzodiazepines | |
AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
AU7956191A (en) | Transportsystem | |
AU7726391A (en) | Slitterscorer | |
AU617287B3 (en) | Receptacle | |
AU6426290A (en) | Container | |
AU4930490A (en) | Can end | |
AU8740291A (en) | 3d-spectacles | |
AU7566691A (en) | Compostor | |
AU8200491A (en) | Facilitating endoscopy | |
AU7587991A (en) | Electrodermatome | |
AU5791490A (en) | Container | |
AU8920091A (en) | Container structure | |
AU8984191A (en) | Thiadiazinones | |
AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles | |
AU8657991A (en) | Hand-saws | |
AU5711090A (en) | Trailer-barrow | |
AU664878B2 (en) | An improved container | |
AU8675791A (en) | Container | |
AU8669591A (en) | Container |